DSM-Firmenich AG

Informe acción LSE:0NPP

Capitalización de mercado: US$0

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

DSM-Firmenich Resultados de beneficios anteriores

Pasado controles de criterios 1/6

DSM-Firmenich's earnings have been declining at an average annual rate of -20.7%, while the Chemicals industry saw earnings declining at 0.8% annually. Revenues have been declining at an average rate of 0.8% per year. DSM-Firmenich's return on equity is 4.4%, and it has net margins of 5.4%.

Información clave

-20.7%

Tasa de crecimiento de los beneficios

-20.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals 4.3%
Tasa de crecimiento de los ingresos-0.8%
Rentabilidad financiera4.4%
Margen neto5.4%
Próxima actualización de resultados02 Aug 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero DSM-Firmenich. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

LSE:0NPP Ingresos, gastos y beneficios ( )
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Dec 228,3904541,772295
30 Sep 229,582837895162
30 Jun 229,8021,0821,789323
31 Mar 229,5031,0811,789323
31 Dec 217,2698201,649274
30 Sep 217,9556602,517560
30 Jun 217,5584931,622398
31 Mar 217,5724231,622398
31 Dec 208,1064481,622398
30 Sep 207,9605101,639295
30 Jun 208,0345571,639295
31 Mar 209,0117221,795349
31 Dec 197,9986751,639295
30 Sep 198,2728201,839348
30 Jun 198,5027941,839348
31 Mar 199,1249341,839348
31 Dec 189,2671,0691,839348
30 Sep 189,2359841,753334
30 Jun 189,1062,0821,753334
31 Mar 188,9081,9421,753334
31 Dec 178,6321,7611,753334
30 Sep 178,4711,6761,694309
30 Jun 178,3337381,694309
31 Mar 178,1667111,694309
31 Dec 167,9206451,694309
30 Sep 167,8315881,605332
30 Jun 167,7782741,605332
31 Mar 167,7492141,605332
31 Dec 157,7221741,605332
30 Sep 157,607661,382304
30 Jun 157,4561141,382304
31 Mar 157,2451151,382304
31 Dec 147,0511231,382304
30 Sep 147,4151121,430340
30 Jun 147,8341381,430340
31 Mar 148,3621821,430340
31 Dec 138,8582521,430340
30 Sep 138,4093631,396372
30 Jun 138,5003351,396372
31 Mar 138,4862571,396372
31 Dec 128,5882801,396372
30 Sep 129,0894531,356378
30 Jun 129,1075431,356378

Ingresos de calidad: 0NPP has high quality earnings.

Margen de beneficios creciente: 0NPP's current net profit margins (5.4%) are lower than last year (11.3%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 0NPP's earnings have declined by 20.7% per year over the past 5 years.

Acelerando crecimiento: 0NPP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Beneficios vs. Industria: 0NPP had negative earnings growth (-44.6%) over the past year, making it difficult to compare to the Chemicals industry average (2.6%).

Rentabilidad financiera

Alta ROE: 0NPP's Return on Equity (4.4%) is considered low.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y